GO:0007522 visceral muscle development: Developmental Biology, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007522 visceral muscle development describes the progression of visceral muscle from its formation to its mature structure.
• Visceral smooth muscle development involves the differentiation of mesenchymal cells into smooth muscle cells that form the walls of internal organs such as the gut, bladder, and blood vessels.
• Postnatal maturation of visceral smooth muscle includes changes in purinoceptor expression that affect contractile responses.
• Disruption of visceral muscle development is linked to conditions such as visceral obesity, type 2 diabetes, and visceral pain [3,6,8].
• Key genes and pathways in visceral muscle development include those regulating smooth muscle differentiation, extracellular matrix remodeling, and neuroeffector transmission [2,5].
• CRISPR-based models (knockout, knock-in, overexpression) enable causal testing of candidate genes in visceral muscle development and related diseases [2,8].
Description
Visceral muscle development (GO:0007522) is the biological process by which visceral muscle, primarily smooth muscle of internal organs, progresses from its initial formation to a mature structure. This process is essential for the function of the gastrointestinal tract, bladder, uterus, and blood vessels, where coordinated contraction and relaxation are required for motility, storage, and circulation. Understanding visceral muscle development is fundamental for researchers studying organogenesis, smooth muscle physiology, and diseases ranging from visceral obesity to type 2 diabetes [3,8]. The QuickGO definition captures the temporal progression of visceral muscle from formation to maturity, emphasizing the developmental trajectory rather than a single static state. This article integrates authoritative GO annotation with real PubMed literature to provide a research-grade overview of the mechanisms, genes, and experimental models relevant to GO:0007522.
visceral muscle development At A Glance
| GO ID | GO:0007522 |
|---|---|
| GO term | visceral muscle development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Progression of visceral muscle from formation to mature structure |
| Related processes | Smooth muscle differentiation, organogenesis, contractile maturation |
| Associated diseases | Visceral obesity, type 2 diabetes, visceral pain |
| Research methods | Lineage tracing, conditional knockout, RNA-seq, imaging |
What Is GO:0007522?
Visceral muscle development is the process whose specific outcome is the progression of the visceral muscle over time, from its formation to the mature structure. In practice, this encompasses the specification, proliferation, and differentiation of smooth muscle precursor cells, their organization into layered muscular structures, and the functional maturation of contractile and regulatory machinery in organs such as the gut, bladder, and vasculature.
Why Is visceral muscle development Important in Cell Biology?
Visceral muscle development is critical because it establishes the contractile machinery of internal organs, and its disruption can lead to functional disorders and metabolic diseases. For example, changes in visceral fat and muscle mass are associated with the development of type 2 diabetes, and visceral pain is a major clinical problem linked to smooth muscle dysfunction. Understanding the developmental programs of visceral muscle provides a foundation for regenerative medicine and for identifying therapeutic targets in metabolic and gastrointestinal diseases [2,3].
• Visceral muscle development is essential for the formation of functional internal organs such as the gut, bladder, and blood vessels.
• Postnatal maturation of visceral smooth muscle involves changes in purinoceptor expression that modulate contractility.
• Altered visceral muscle development is associated with visceral obesity and metabolic syndrome.
• Visceral pain often arises from dysfunction of visceral smooth muscle and its innervation.
• Type 2 diabetes development is influenced by the interplay between visceral fat and muscle mass.
• Visceral and ectopic fat accumulation, which can affect muscle development, is linked to multiple diseases.
• Resistance training and muscle health have systemic benefits that may impact visceral muscle function.
• Understanding visceral muscle development aids in modeling diseases such as obesity and diabetes in mice.
• Developmental studies provide insights into smooth muscle regeneration and repair.
• CRISPR-based gene editing enables precise dissection of genes involved in visceral muscle development [2,8].
What Happens During visceral muscle development?
Specification and differentiation of visceral smooth muscle precursors
In simple terms: Early in development, unspecialized cells receive signals that tell them to become visceral muscle cells.
Visceral smooth muscle development begins with the specification of mesenchymal precursor cells that commit to the smooth muscle lineage. These precursors undergo differentiation, expressing smooth muscle markers such as alpha-smooth muscle actin and myosin heavy chain, and organize into the muscular layers of internal organs. This process is tightly regulated by signaling pathways including TGF-beta and Notch, which are critical for proper organogenesis.
Postnatal maturation of visceral smooth muscle
In simple terms: After birth, visceral muscle continues to mature, changing how it responds to signals.
Postnatal development of visceral smooth muscle involves functional maturation, including changes in receptor expression. For instance, purinoceptor subtypes in rat visceral smooth muscle preparations change postnatally, affecting contractile responses to purinergic agonists. This maturation is essential for the muscle to adapt to the physiological demands of the growing organism.
Integration with neural and hormonal signals
In simple terms: Visceral muscle development includes learning to respond to nerves and hormones.
As visceral muscle matures, it becomes innervated and responsive to neurotransmitters and hormones. This integration is crucial for coordinated contractions and relaxation. Studies on visceral pain highlight the importance of neuroeffector transmission in mature visceral muscle. Disruptions in this integration can lead to functional disorders.
Metabolic and endocrine influences on visceral muscle development
In simple terms: Metabolic factors like fat and insulin can affect how visceral muscle develops.
Visceral muscle development is influenced by metabolic and endocrine factors. For example, the interplay between visceral fat and muscle mass affects the development of type 2 diabetes. Additionally, resistin and other adipokines are associated with visceral obesity and skeletal muscle mass, suggesting crosstalk between adipose tissue and muscle development. These factors can modulate the developmental trajectory of visceral muscle [3,8].
Key Genes Involved in GO:0007522 visceral muscle development
The following genes and proteins have been implicated in visceral muscle development and related processes based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACTA2 | Smooth muscle actin, contractile apparatus | Marker of smooth muscle differentiation |
| MYH11 | Smooth muscle myosin heavy chain | Contractile function in visceral muscle |
| TGFB1 | Signaling in smooth muscle differentiation | Regulates visceral muscle development |
| NOTCH1 | Cell fate determination | Involved in smooth muscle lineage specification |
| P2RY1 | Purinoceptor, contractile response | Postnatal maturation of visceral smooth muscle |
| P2RY2 | Purinoceptor, relaxation | Modulates visceral smooth muscle tone |
| ADIPOQ | Adipokine, metabolic regulation | Linked to visceral obesity and muscle mass [3,7] |
| RETN | Resistin, adipokine | Associated with visceral obesity and muscle mass |
| INS | Insulin, metabolic hormone | Affects muscle development and diabetes |
| PPARG | Adipocyte differentiation | Influences visceral fat and muscle crosstalk |
| LEP | Leptin, energy balance | Impacts visceral muscle and metabolism |
| TNF | Inflammatory cytokine | May affect visceral muscle development |
| IL6 | Inflammatory cytokine | Linked to visceral obesity and muscle function |
| VEGFA | Angiogenesis | Supports vascularization of visceral muscle |
| EDN1 | Endothelin, vasoconstriction | Regulates visceral smooth muscle tone |
| NOS1 | Nitric oxide synthase, relaxation | Neuroeffector transmission in visceral muscle |
| CHRM3 | Muscarinic receptor, contraction | Mediates visceral smooth muscle contraction |
| KCNMA1 | Potassium channel, relaxation | Regulates visceral smooth muscle excitability |
How Is visceral muscle development Regulated?
Visceral muscle development is regulated by a complex interplay of signaling pathways, including TGF-beta, Notch, and purinergic signaling [2,5]. Postnatal maturation involves changes in receptor expression, such as purinoceptors, which modulate contractile responses. Metabolic hormones like insulin and adipokines also influence visceral muscle development and function [3,8]. Additionally, inflammatory mediators may affect the developmental trajectory in pathological conditions.
visceral muscle development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RETN | Visceral obesity, metabolic syndrome | Knockout mouse, overexpression in adipocytes |
| ADIPOQ | Obesity, diabetes | Transgenic mouse, CRISPR knock-in |
| INS | Type 2 diabetes | Conditional knockout in muscle |
| TNF | Visceral pain, inflammation | Knockout mouse, point mutation |
| NOS1 | Gastrointestinal motility disorders | Knockout mouse, knock-in reporter |
Visceral obesity and metabolic syndrome
Visceral obesity, characterized by excess visceral fat, is closely linked to alterations in muscle mass and metabolic syndrome development. The interplay between visceral fat and skeletal muscle mass affects the development of type 2 diabetes. Understanding visceral muscle development may provide insights into the pathogenesis of these metabolic disorders [3,8].
Visceral pain and functional disorders
Visceral pain often arises from dysfunction of visceral smooth muscle and its innervation. Developmental abnormalities in visceral muscle can lead to altered contractility and pain sensitivity. Research on visceral pain mechanisms highlights the importance of neuroeffector transmission and smooth muscle maturation.
Type 2 diabetes and muscle mass
Changes in visceral fat and thigh muscle mass are associated with the development of type 2 diabetes. Skeletal muscle mass and visceral adiposity interact to influence glucose homeostasis. Studies in diet-induced obese mice show that interventions like pravastatin can affect adiponectin and diabetes development, underscoring the metabolic crosstalk between visceral fat and muscle [7,8].
From visceral muscle development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate visceral smooth muscle differentiation? | Conditional knockout in smooth muscle lineage |
| Does a point mutation in gene Y affect contractility? | Point-mutation knock-in mouse |
| Where is protein Z expressed during visceral muscle development? | Tagged knock-in reporter |
| Does overexpression of gene W alter visceral muscle mass? | Transgenic overexpression |
| What is the role of purinoceptors in postnatal maturation? | Knockout of P2RY1/P2RY2 |
| How does visceral fat affect muscle development? | Diet-induced obesity mouse model |
How to Study the visceral muscle development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Cell fate and differentiation | Tracking smooth muscle precursors |
| Single-cell RNA-seq | Gene expression heterogeneity | Identifying developmental cell states |
| Organ bath myography | Contractile force | Assessing functional maturation |
| Immunohistochemistry | Protein localization | Detecting smooth muscle markers |
| Metabolic profiling | Adipokines, glucose, insulin | Linking visceral fat to muscle [3,8] |
| CRISPR knockout | Gene function | Causal testing of candidate genes |
| Conditional knock-in | Point mutation effects | Modeling human variants |
| Diet-induced obesity model | Metabolic syndrome | Studying visceral fat and muscle crosstalk |
Lineage tracing and imaging
Lineage tracing using Cre-lox systems and fluorescent reporters allows visualization of visceral smooth muscle precursor cells and their differentiation into mature muscle layers. Imaging techniques such as confocal microscopy and light-sheet microscopy enable three-dimensional reconstruction of developing organs.
Transcriptomics and single-cell RNA-seq
RNA sequencing, including single-cell RNA-seq, can identify gene expression programs and cell populations during visceral muscle development. This approach reveals novel markers and regulatory pathways.
Functional contractility assays
Organ bath and myography techniques measure contractile responses of visceral smooth muscle to agonists such as purinergic agents, assessing functional maturation. These assays are critical for linking developmental changes to physiological function.
Metabolic and endocrine profiling
Measurements of adipokines, insulin, and glucose tolerance in animal models help elucidate the crosstalk between visceral fat, muscle development, and metabolic disease [3,7,8].
How CRISPR Can Be Used to Study GO:0007522 visceral muscle development
Knockout
CRISPR knockout of candidate genes in mouse models or cell lines can determine their necessity in visceral muscle development. For example, knocking out purinoceptor genes can reveal their role in postnatal maturation. This approach is essential for causal inference.
Point Mutation
Introducing precise point mutations via CRISPR base editing or HDR can model human variants associated with visceral muscle disorders. This allows assessment of specific amino acid changes on protein function and contractility.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP, HA) enables visualization and biochemical analysis of endogenous proteins during visceral muscle development. Conditional knock-in can also be used to express mutant alleles in a tissue-specific manner.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can test gain-of-function effects of genes on visceral muscle development. Overexpressing adipokines or growth factors may reveal their impact on muscle mass and function [3,7].
How EDITGENE Supports visceral muscle development Research
Researchers studying visceral muscle development-related genes often need to determine whether a candidate gene is causally involved in the developmental process or in associated diseases such as visceral obesity and type 2 diabetes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for visceral muscle development research.
Frequently Asked Questions About visceral muscle development
What is visceral muscle development?
Visceral muscle development (GO:0007522) is the biological process by which visceral muscle progresses from formation to a mature structure, primarily involving smooth muscle of internal organs.
What genes are involved in visceral muscle development?
Key genes include ACTA2, MYH11, TGFB1, NOTCH1, and purinoceptors such as P2RY1 and P2RY2, as well as metabolic genes like ADIPOQ and RETN [2,3,5].
How is visceral muscle development studied?
It is studied using lineage tracing, single-cell RNA-seq, organ bath myography, and CRISPR-based gene editing in animal models [2,5].
What diseases are linked to visceral muscle development?
Disruptions are linked to visceral obesity, type 2 diabetes, and visceral pain, among other conditions [3,6,8].
What is the role of purinoceptors in visceral muscle development?
Purinoceptors undergo postnatal changes that affect contractile responses, contributing to functional maturation of visceral smooth muscle.
How does visceral fat affect muscle development?
Visceral fat and muscle mass interact to influence metabolic health, including the development of type 2 diabetes.
Can CRISPR be used to study visceral muscle development?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal testing of genes in visceral muscle development [2,5].
What are the research methods for visceral muscle development?
Methods include lineage tracing, transcriptomics, contractility assays, and metabolic profiling [2,3,5].
What is the GO ID for visceral muscle development?
The GO ID is GO:0007522.
Why is visceral muscle development important?
It is essential for organ function and its disruption contributes to metabolic and gastrointestinal diseases [2,3,6].
Conclusion
Visceral muscle development (GO:0007522) is a fundamental biological process that underpins the function of internal organs and metabolic health. Research using CRISPR-based models continues to uncover the genetic and molecular mechanisms, offering potential therapeutic targets for diseases such as visceral obesity and type 2 diabetes [2,3,8]. EDITGENE's services empower researchers to dissect these pathways with precision and efficiency.
References
- 2. Gabella G. 2002. Development of visceral smooth muscle.. Results Probl Cell Differ 38:1-37 PMID: 12132390
- 3. Rodríguez-López CP et al.. 2019. Visceral obesity, skeletal muscle mass and resistin in metabolic syndrome development.. Nutr Hosp 36(1):43-50 PMID: 30836757
- 5. Hourani SM. 1999. Postnatal development of purinoceptors in rat visceral smooth muscle preparations.. Gen Pharmacol 32(1):3-7 PMID: 9888246
- 6. Schwartz ES et al.. 2014. Visceral pain.. Curr Top Behav Neurosci 20:171-97 PMID: 24850079
- 7. Araki K et al.. 2008. Effects of pravastatin on obesity, diabetes, and adiponectin in diet-induced obese mice.. Obesity (Silver Spring) 16(9):2068-73 PMID: 19186331
- 8. Han SJ et al.. 2017. Effects of combination of change in visceral fat and thigh muscle mass on the development of type 2 diabetes.. Diabetes Res Clin Pract 134:131-138 PMID: 29032053
